However, the cumulative methylation level of significant CpG sites in CYP24A1 was significantly lower in colorectal cancer cases than that in controls, and it was significantly negatively associated with colorectal cancer risk, which was consistent with our hypothesis. This evidence concerns the gene CYP24A1 and colorectal cancer.